Выберите направление
Выберите страну
Выберите город
Выберите направление
Выберите страну
Выберите город

Лучшие в мире врачи

Контент соответствует редакционной политике Bookimed и его качество проверил
Фахад Мавлюд - Врач общей практики, лауреат 4 конкурсов научных работ молодых ученых. Работал на Среднем Востоке. Бывший руководитель команды англоязычных и арабоязычных врачей-координаторов. Сейчас занимается анализом данных и выступает медицинским редактором сайта.
Hasan Atilla Ozkan
23 года опыта
5.0
1 отзыв
Turkey, Istanbul
VM Medical Park Pendik Hospital

Hasan Atilla Ozkan

23 года опыта

Education & Expertise

  • 1997 | Hacettepe University Faculty of Medicine – Medical Degree
  • 2003 | Uludağ University Faculty of Medicine – Internal Medicine Specialization
  • 2007 | Uludağ University Faculty of Medicine – Hematology Subspecialty

Professional Experience

  • 1998 (May – September) | Practitioner, Dr. Salaha Health Center, Rize
  • 1998 to 2003 | Research Assistant, Uludağ University Faculty of Medicine, Internal Medicine Department
  • 2003 to 2007 | Hematology Subspecialist, Uludağ University Faculty of Medicine, Hematology Division
  • 2007 to 2011 | Hematology Specialist, Bursa Ali Osman Sönmez Oncology Hospital (Compulsory Service)
  • 2011 to 2013 | Hematology Specialist, Private Anadolu Health Center Bone Marrow Transplant Center, Gebze
  • 2014 to 2015 | Assistant Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
  • 2015 to 2020 | Associate Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
  • 2020 to Present | Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine

Courses & Certifications

  • Autologous and Allogeneic Stem Cell Transplantation Certificate
  • Clinical Phytotherapy Application Certificate
  • Flow Cytometry Experience Certificate
  • EBMT Stem Cell Transplantation Course

Professional Memberships

  • Turkish Medical Chamber
  • Turkish Hematology Association (Full Member, No: 893)
  • Turkish Therapeutic Apheresis Association (Current President)
  • Geriatric Hematology Association
  • Hematological Oncology Association
  • EBMT (European Bone Marrow Transplantation)

Awards & Recognitions

  • 2011 | 6th Turkish Therapeutic Apheresis Congress – Young Researcher Award
Читать подробнее

Education & Expertise

  • 1997 | Hacettepe University Faculty of Medicine – Medical Degree
  • 2003 | Uludağ University Faculty of Medicine – Internal Medicine Specialization
  • 2007 | Uludağ University Faculty of Medicine – Hematology Subspecialty

Professional Experience

  • 1998 (May – September) | Practitioner, Dr. Salaha Health Center, Rize
  • 1998 to 2003 | Research Assistant, Uludağ University Faculty of Medicine, Internal Medicine Department
  • 2003 to 2007 | Hematology Subspecialist, Uludağ University Faculty of Medicine, Hematology Division
  • 2007 to 2011 | Hematology Specialist, Bursa Ali Osman Sönmez Oncology Hospital (Compulsory Service)
  • 2011 to 2013 | Hematology Specialist, Private Anadolu Health Center Bone Marrow Transplant Center, Gebze
  • 2014 to 2015 | Assistant Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
  • 2015 to 2020 | Associate Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine
  • 2020 to Present | Professor, Yeditepe University Faculty of Medicine, Department of Internal Medicine

Courses & Certifications

  • Autologous and Allogeneic Stem Cell Transplantation Certificate
  • Clinical Phytotherapy Application Certificate
  • Flow Cytometry Experience Certificate
  • EBMT Stem Cell Transplantation Course

Professional Memberships

  • Turkish Medical Chamber
  • Turkish Hematology Association (Full Member, No: 893)
  • Turkish Therapeutic Apheresis Association (Current President)
  • Geriatric Hematology Association
  • Hematological Oncology Association
  • EBMT (European Bone Marrow Transplantation)

Awards & Recognitions

  • 2011 | 6th Turkish Therapeutic Apheresis Congress – Young Researcher Award
Читать подробнее
Suber Dikici
25 лет опыта
5.0
1 отзыв
Turkey, Istanbul
VM Medical Park Pendik Hospital

Suber Dikici

25 лет опыта

Education & Expertise

1996 to 2000 | Dicle University – Medical Education

 

Professional Experience

2001 to 2006 | Diyarbakır State Hospital – Neurology Specialist

2006 to 2009 | Düzce Atatürk State Hospital – Neurology Specialist

2009 to 2013 | Düzce University – Associate Professor of Neurology

2013 to 2016 | Düzce University – Associate Professor of Neurology

2017 to 2024 | Pendik Private Century Hospital – Associate Professor of Neurology

2024 to Present | VM Medical Park Pendik Hospital – Associate Professor of Neurology

 

Courses & Certifications

June, 2012 | Trainer Training Course

February, 2010 | Trainer Training Course

March, 2011 | Sleep Medicine Certification Program Preparation Course

December, 2012 | Sleep Disorders Diagnosis and Treatment Course

DBS Application Training and Course – Dubai

 

Professional Memberships

Turkish Medical Association

Turkish Neurology Association

Turkish Sleep Medicine Association

 

Awards & Recognitions

2014 | Düzce University Rectorship – Publication Success Incentive Award

Читать подробнее

Education & Expertise

1996 to 2000 | Dicle University – Medical Education

 

Professional Experience

2001 to 2006 | Diyarbakır State Hospital – Neurology Specialist

2006 to 2009 | Düzce Atatürk State Hospital – Neurology Specialist

2009 to 2013 | Düzce University – Associate Professor of Neurology

2013 to 2016 | Düzce University – Associate Professor of Neurology

2017 to 2024 | Pendik Private Century Hospital – Associate Professor of Neurology

2024 to Present | VM Medical Park Pendik Hospital – Associate Professor of Neurology

 

Courses & Certifications

June, 2012 | Trainer Training Course

February, 2010 | Trainer Training Course

March, 2011 | Sleep Medicine Certification Program Preparation Course

December, 2012 | Sleep Disorders Diagnosis and Treatment Course

DBS Application Training and Course – Dubai

 

Professional Memberships

Turkish Medical Association

Turkish Neurology Association

Turkish Sleep Medicine Association

 

Awards & Recognitions

2014 | Düzce University Rectorship – Publication Success Incentive Award

Читать подробнее
Cemil Bilir
21 год опыта
5.0
1 отзыв
Turkey, Istanbul
VM Medical Park Pendik Hospital

Cemil Bilir

21 год опыта

Education & Expertise

  • 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
  • 2005 to 2009 – Düzce University, Internal Medicine Specialization
  • 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
  • 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
  • 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
  • 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
  • 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
  • 2020 to Present – Professor, Sakarya University Faculty of Medicine
  • 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

  • 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
  • 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

  • TTOD (Turkish Society of Medical Oncology)
  • ASCO (American Society of Clinical Oncology)
  • ESMO (European Society for Medical Oncology)
Читать подробнее

Education & Expertise

  • 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
  • 2005 to 2009 – Düzce University, Internal Medicine Specialization
  • 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
  • 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
  • 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
  • 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
  • 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
  • 2020 to Present – Professor, Sakarya University Faculty of Medicine
  • 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

  • 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
  • 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

  • TTOD (Turkish Society of Medical Oncology)
  • ASCO (American Society of Clinical Oncology)
  • ESMO (European Society for Medical Oncology)
Читать подробнее
Fatih Yildiz
14 лет опыта
5.0
1 отзыв
Turkey, Istanbul
Memorial Göztepe Hospital

Fatih Yildiz

14 лет опыта

Dr. Fatih Yildiz is an Orthopedics and Traumatology Specialist at Memorial Göztepe Hospital, Istanbul (2025–present). He previously worked at Bezmialem Foundation University, Faculty of Medicine (2013–2025). He also worked at Kızıltepe State Hospital, Mardin (2012–2013). He completed his Orthopedics and Traumatology residency at Istanbul University, Istanbul Faculty of Medicine (2006–2012). He earned his MD from the same faculty (1999–2005).

Professional memberships: TOTBİD (Turkish Orthopedics and Traumatology Association), TOTDER (Turkish Society of Orthopedics and Traumatology), and TOTEK (Turkish Orthopedics and Traumatology Education Council).

Читать подробнее

Dr. Fatih Yildiz is an Orthopedics and Traumatology Specialist at Memorial Göztepe Hospital, Istanbul (2025–present). He previously worked at Bezmialem Foundation University, Faculty of Medicine (2013–2025). He also worked at Kızıltepe State Hospital, Mardin (2012–2013). He completed his Orthopedics and Traumatology residency at Istanbul University, Istanbul Faculty of Medicine (2006–2012). He earned his MD from the same faculty (1999–2005).

Professional memberships: TOTBİD (Turkish Orthopedics and Traumatology Association), TOTDER (Turkish Society of Orthopedics and Traumatology), and TOTEK (Turkish Orthopedics and Traumatology Education Council).

Читать подробнее
Yusuf Pirincci
30 лет опыта
5.0
3 отзыва
Turkey, Istanbul
Atlas University Hospital

Yusuf Pirincci

30 лет опыта

1997 - 2002 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Orthopedics and Traumatology

1990 - 1996 Istanbul University Cerrahpasa Faculty of Medicine

 

Articles he wrote and contributed to;

Clinical efficacy of peritendinous platelet-rich plasma injection in the treatment of tendinopathies: A retrospective study Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Medium and long-term effects of acetabular roof ring and Burch-Schneider anti-protusio cages in acetabular revisions in patients with acetabular bone deficiency Correspondence: Yusuf Pirinççi , Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Dimensional variables of the proximal femur in developmental adult hip dysplasia suggest that a tapered, rectangular, press-fit design may be an optimal choice for patients with Crowe type IV hips

 

Specialties

Limb Lenghtening 

Sports Surgery

Meniscus Tears

Anterior Cruciate Ligament Tears

Knee Prosthesis

Hip Prosthesis

Shoulder Prosthesis

Shoulder Slap Repair

Height Extension

Tumor Surgery

Foot Surgery( Hallux Valgus)

Diabetic Foot

Bone Infections (Osteomyelitis)

Читать подробнее

1997 - 2002 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Orthopedics and Traumatology

1990 - 1996 Istanbul University Cerrahpasa Faculty of Medicine

 

Articles he wrote and contributed to;

Clinical efficacy of peritendinous platelet-rich plasma injection in the treatment of tendinopathies: A retrospective study Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Medium and long-term effects of acetabular roof ring and Burch-Schneider anti-protusio cages in acetabular revisions in patients with acetabular bone deficiency Correspondence: Yusuf Pirinççi , Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Dimensional variables of the proximal femur in developmental adult hip dysplasia suggest that a tapered, rectangular, press-fit design may be an optimal choice for patients with Crowe type IV hips

 

Specialties

Limb Lenghtening 

Sports Surgery

Meniscus Tears

Anterior Cruciate Ligament Tears

Knee Prosthesis

Hip Prosthesis

Shoulder Prosthesis

Shoulder Slap Repair

Height Extension

Tumor Surgery

Foot Surgery( Hallux Valgus)

Diabetic Foot

Bone Infections (Osteomyelitis)

Читать подробнее
Emin Orkun Olcay
9 лет опыта
Turkey, Istanbul
İstinye Dental Hospital

Emin Orkun Olcay

9 лет опыта

Specialization: Periodontology

Areas of Interest

-Gum Diseases

-Treatment of Peri-Implant Diseases

-Bone Loss Therapies

-Gum Aesthetics

-Halitosis (Mouth Odor)

Education

2018 – DDS, Başkent University Faculty of Dentistry

2021 – Undergraduate in Health Management, Anadolu University

2022 – Ph.D. in Periodontology, Gazi University

Professional Experience

2018 to 2022 – Research Assistant, Gazi University, Department of Periodontology

2021–Present – Head, Istinye University Oral and Dental Health Program

2021–Present – Trainer, Praticmed Dentistry (Suture & Flap Closure Training)

Courses & Certifications

-Suture & Flap Closure Training in Dentistry (Trainer), 2021

-TDB International Dentistry Congress, 2022

-ERDİŞ International Dentistry Congress (Oral Presentation), 2023

-Emergency Skills in Oral and Maxillofacial Surgery, London, UK, 2016

-AOCMF Course, Craniomaxillofacial Fracture Management, İzmir, 2016

-Bego Implant Advanced Surgery Course, Germany, 2014

Professional Memberships

-Turkish Dental Association (TDB)

-Turkish Periodontology Association

-KÖKDİŞ National Council

Research & Publications

A New Dimension in Periodontal Regenerative Therapy: 3D Cell Culture. ADO Klinik Bilimler, 2023.

Doctoral Thesis: Evaluation of the osteogenic potential of periodontium-derived mesenchymal stem cells in 2D and 3D culture environments.

Читать подробнее

Specialization: Periodontology

Areas of Interest

-Gum Diseases

-Treatment of Peri-Implant Diseases

-Bone Loss Therapies

-Gum Aesthetics

-Halitosis (Mouth Odor)

Education

2018 – DDS, Başkent University Faculty of Dentistry

2021 – Undergraduate in Health Management, Anadolu University

2022 – Ph.D. in Periodontology, Gazi University

Professional Experience

2018 to 2022 – Research Assistant, Gazi University, Department of Periodontology

2021–Present – Head, Istinye University Oral and Dental Health Program

2021–Present – Trainer, Praticmed Dentistry (Suture & Flap Closure Training)

Courses & Certifications

-Suture & Flap Closure Training in Dentistry (Trainer), 2021

-TDB International Dentistry Congress, 2022

-ERDİŞ International Dentistry Congress (Oral Presentation), 2023

-Emergency Skills in Oral and Maxillofacial Surgery, London, UK, 2016

-AOCMF Course, Craniomaxillofacial Fracture Management, İzmir, 2016

-Bego Implant Advanced Surgery Course, Germany, 2014

Professional Memberships

-Turkish Dental Association (TDB)

-Turkish Periodontology Association

-KÖKDİŞ National Council

Research & Publications

A New Dimension in Periodontal Regenerative Therapy: 3D Cell Culture. ADO Klinik Bilimler, 2023.

Doctoral Thesis: Evaluation of the osteogenic potential of periodontium-derived mesenchymal stem cells in 2D and 3D culture environments.

Читать подробнее
Caner Gelbal
9 лет опыта
4.5
2 отзыва
Turkey, Istanbul
Medipol Bahçelievler Hospital

Caner Gelbal

9 лет опыта

CANER GELBAL, MD

Birth Date : January 16, 1993 year

Birth Place : İstanbul, Turkey


Education, Awards and Certifications

  • Inter High School Olympic Competition,Ankara Science High School Olympic Team Captain,Scientific and Technological Research Council of Turkey(TUBİTAK)-2009 year
  • Ankara Science High School-2007-2010 year
  • İzmir Science High School – 2010-2011 year 
  • Istanbul University School of Medicine – 2017 year 
  • Animal Research Certificate – January 2019 year 
  • Microsurgery Certificate- May 2019 year 
  • Bagcilar Research and Training Hospital , Department  of Plastic,Reconstructive and Aesthetic Surgery  - 2018 year – Current
     

Rotations

November 2018 year - April 2019 year  - General Surgery Rotation - Bagcilar Research and Training Hospital Department of General Surgery

April - May 2019 year - Orthopedia Rotation - Bagcilar Research and Training Hospital Department of Orthopedia


Articles published in nationally-respected journals: 

1. Tatar BE, Gelbal C, Sezgiç M, Karakol P, Uslu C, Kabul S. A Rare Case: Malignant Granular Cell Tumor in Axillary Region.

Oral Presentations in International Meetings

1.Using Mandibular Bony Tissues Which Are Treated with Liquid Nitrogen As Scaffold For Partial Femoral Transplantation in Mandible Reconstruction and Evaluation of Bone Survival: Experimental Rat Femur Transplantation Model 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt 

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

2. The Effect of Centrifuge Duration on Fat Graft Survival 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

3. Are the permanent effects of renal failure not so permanent? 

Percin Karakol, Caner Gelbal, Can Uslu, Burak Ergün Tatar, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

Oral Presentations in national Meetings:

1.Üst ekstremite acil ve elektif vakalarda WALANT’ın kullanımı.                                   

Burak Ergün Tatar, Perçin Karakol, Can Uslu, Caner Gelbal  41. Ulusal Plastik Cerrahi Kurultayı, 26-30 October, 2019 year, Samsun,Turkey

Читать подробнее

CANER GELBAL, MD

Birth Date : January 16, 1993 year

Birth Place : İstanbul, Turkey


Education, Awards and Certifications

  • Inter High School Olympic Competition,Ankara Science High School Olympic Team Captain,Scientific and Technological Research Council of Turkey(TUBİTAK)-2009 year
  • Ankara Science High School-2007-2010 year
  • İzmir Science High School – 2010-2011 year 
  • Istanbul University School of Medicine – 2017 year 
  • Animal Research Certificate – January 2019 year 
  • Microsurgery Certificate- May 2019 year 
  • Bagcilar Research and Training Hospital , Department  of Plastic,Reconstructive and Aesthetic Surgery  - 2018 year – Current
     

Rotations

November 2018 year - April 2019 year  - General Surgery Rotation - Bagcilar Research and Training Hospital Department of General Surgery

April - May 2019 year - Orthopedia Rotation - Bagcilar Research and Training Hospital Department of Orthopedia


Articles published in nationally-respected journals: 

1. Tatar BE, Gelbal C, Sezgiç M, Karakol P, Uslu C, Kabul S. A Rare Case: Malignant Granular Cell Tumor in Axillary Region.

Oral Presentations in International Meetings

1.Using Mandibular Bony Tissues Which Are Treated with Liquid Nitrogen As Scaffold For Partial Femoral Transplantation in Mandible Reconstruction and Evaluation of Bone Survival: Experimental Rat Femur Transplantation Model 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt 

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

2. The Effect of Centrifuge Duration on Fat Graft Survival 

Percin Karakol, Burak Ergün Tatar, Can Uslu, Caner Gelbal, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

3. Are the permanent effects of renal failure not so permanent? 

Percin Karakol, Caner Gelbal, Can Uslu, Burak Ergün Tatar, Mehmet Bozkurt

11th European Plastic Surgery Research Council August 23-25, 2018 year, Munich, Germany

Oral Presentations in national Meetings:

1.Üst ekstremite acil ve elektif vakalarda WALANT’ın kullanımı.                                   

Burak Ergün Tatar, Perçin Karakol, Can Uslu, Caner Gelbal  41. Ulusal Plastik Cerrahi Kurultayı, 26-30 October, 2019 year, Samsun,Turkey

Читать подробнее
Taha Elkhatroushi
10 лет опыта
4.5
2 отзыва
Turkey, Istanbul
Medipol Bahçelievler Hospital

Taha Elkhatroushi

10 лет опыта

TAHA ELKHATROUSHI
Otorhinolaryngologist (ENT Specialist)

PUBLICATIONS
    •    Comparison of different surgical branches’ perspectives on 3D printing technology. 16th Turkish Rhinology Congress, 2022.
    •    Olfactory and Taste Dysfunction During the COVID-19 Pandemic: A Multicenter Study. 43rd National ENT Congress, 2022.
    •    Virtual Modeling and 3D Printing in ENT Surgery. 8th ENT Spring Meeting, 2023.
    •    EuroSurg Collaborative. Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta-analysis. Colorectal Disease, 2018.
    •    The Use of Three-Dimensional Printed Technology for Mandibular Reconstruction in a Rare Case of Giant Odontogenic Myxofibroma. Journal of Craniofacial Surgery, 2021.

WORK EXPERIENCE

2019–2024
Istanbul University - Cerrahpaşa Medical Faculty
Department of Otorhinolaryngology

EDUCATION

2010–2016
Istanbul University - Istanbul Faculty of Medicine

June 2016
University of Iowa, Department of Otolaryngology – Head and Neck Surgery
Research Assistant

September 2023
University of Texas Medical Branch, Department of Otolaryngology – Head and Neck Surgery
Observership

COURSES & CERTIFICATIONS
    •    ECFMG Certification (USMLE Step 1-2-3)
    •    Laboratory Animal Use Certificate, Bezmialem Vakıf University – 2021
    •    Face-to-Face Cadaver Course – 2023

CONGRESSES & MEETINGS
    •    17th National and 2nd International Facial Plastic Surgery Congress / İzmir – 2023
    •    Nosecraft Essentials of Rhinoplasty – 2024
    •    Structure-Preservation Rhinoplasty Conference – 2024

AWARDS
    •    1st Prize for the presentation: Virtual Modeling and 3D Printing in ENT Surgery
8th ENT Spring Meeting, 2023

Читать подробнее

TAHA ELKHATROUSHI
Otorhinolaryngologist (ENT Specialist)

PUBLICATIONS
    •    Comparison of different surgical branches’ perspectives on 3D printing technology. 16th Turkish Rhinology Congress, 2022.
    •    Olfactory and Taste Dysfunction During the COVID-19 Pandemic: A Multicenter Study. 43rd National ENT Congress, 2022.
    •    Virtual Modeling and 3D Printing in ENT Surgery. 8th ENT Spring Meeting, 2023.
    •    EuroSurg Collaborative. Body mass index and complications following major gastrointestinal surgery: a prospective, international cohort study and meta-analysis. Colorectal Disease, 2018.
    •    The Use of Three-Dimensional Printed Technology for Mandibular Reconstruction in a Rare Case of Giant Odontogenic Myxofibroma. Journal of Craniofacial Surgery, 2021.

WORK EXPERIENCE

2019–2024
Istanbul University - Cerrahpaşa Medical Faculty
Department of Otorhinolaryngology

EDUCATION

2010–2016
Istanbul University - Istanbul Faculty of Medicine

June 2016
University of Iowa, Department of Otolaryngology – Head and Neck Surgery
Research Assistant

September 2023
University of Texas Medical Branch, Department of Otolaryngology – Head and Neck Surgery
Observership

COURSES & CERTIFICATIONS
    •    ECFMG Certification (USMLE Step 1-2-3)
    •    Laboratory Animal Use Certificate, Bezmialem Vakıf University – 2021
    •    Face-to-Face Cadaver Course – 2023

CONGRESSES & MEETINGS
    •    17th National and 2nd International Facial Plastic Surgery Congress / İzmir – 2023
    •    Nosecraft Essentials of Rhinoplasty – 2024
    •    Structure-Preservation Rhinoplasty Conference – 2024

AWARDS
    •    1st Prize for the presentation: Virtual Modeling and 3D Printing in ENT Surgery
8th ENT Spring Meeting, 2023

Читать подробнее
Meryem Eken
18 лет опыта
4.4
33 отзыва
Turkey, Istanbul
Medical Park Göztepe Hospital Complex

Meryem Eken

18 лет опыта

Dr. Meryem Eken is an obstetrician-gynecologist and IVF specialist. She earned her M.D. and completed her residency at Istanbul University. She completed IVF clinical training at Zeynep Kamil in 2017. She led the IVF Unit at Hisar Intercontinental Hospital from 2020 to 2025. She heads the IVF Unit at Bahçeşehir University Medical Park Göztepe Hospital. She started in 2025. She has served on the faculty of Üsküdar University since 2024. She became a professor at Biruni University in 2025.

Her clinical focus includes infertility, intrauterine insemination (IUI), natural-cycle IVF, hysteroscopy, endometriosis, and minimally invasive myomectomy. She has authored or co-authored more than 30 peer-reviewed international articles. Several appeared in SCI and SSCI journals. In 2016, she received First Prize for an oral presentation from the Turkish Society of Gynecology and Obstetrics.

Читать подробнее

Dr. Meryem Eken is an obstetrician-gynecologist and IVF specialist. She earned her M.D. and completed her residency at Istanbul University. She completed IVF clinical training at Zeynep Kamil in 2017. She led the IVF Unit at Hisar Intercontinental Hospital from 2020 to 2025. She heads the IVF Unit at Bahçeşehir University Medical Park Göztepe Hospital. She started in 2025. She has served on the faculty of Üsküdar University since 2024. She became a professor at Biruni University in 2025.

Her clinical focus includes infertility, intrauterine insemination (IUI), natural-cycle IVF, hysteroscopy, endometriosis, and minimally invasive myomectomy. She has authored or co-authored more than 30 peer-reviewed international articles. Several appeared in SCI and SSCI journals. In 2016, she received First Prize for an oral presentation from the Turkish Society of Gynecology and Obstetrics.

Читать подробнее
Nail Paksoy
15 лет опыта
4.5
2 отзыва
Turkey, Istanbul
Medipol Bahçelievler Hospital

Nail Paksoy

15 лет опыта


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Читать подробнее


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Читать подробнее
Sule Yildirim Kopuk
18 лет опыта
5.0
1 отзыв
Turkey, Istanbul
VM Medical Park Pendik Hospital

Sule Yildirim Kopuk

18 лет опыта

Education and Expertise

09/2001 to 07/2008 – Marmara University, School of Medicine

02/2009 to 06/2014 – Kocaeli University, School of Medicine, Department of Obstetrics and Gynecology

Experience

09/2008 to 02/2009 – Sultançiftliği Health Clinic, Istanbul

06/2014 to 01/2016 – Khorasan State Hospital

02/2016 to 2019 – Health Science University, Ümraniye Education and Research Hospital, Department of Obstetrics and Gynecology

03/2019 to 04/2023 – Acıbadem Maslak Hospital, IVF Center

Foreign Experience

01/05/2012 to 15/06/2012 – Yale University, School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Section of Maternal-Fetal Medicine, New Haven, Connecticut

23/09/2013 to 04/10/2013 – Nezhat Medical Center, Atlanta Center for Special Minimally Invasive Surgery & Reproductive Medicine, Georgia, Atlanta

Читать подробнее

Education and Expertise

09/2001 to 07/2008 – Marmara University, School of Medicine

02/2009 to 06/2014 – Kocaeli University, School of Medicine, Department of Obstetrics and Gynecology

Experience

09/2008 to 02/2009 – Sultançiftliği Health Clinic, Istanbul

06/2014 to 01/2016 – Khorasan State Hospital

02/2016 to 2019 – Health Science University, Ümraniye Education and Research Hospital, Department of Obstetrics and Gynecology

03/2019 to 04/2023 – Acıbadem Maslak Hospital, IVF Center

Foreign Experience

01/05/2012 to 15/06/2012 – Yale University, School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Section of Maternal-Fetal Medicine, New Haven, Connecticut

23/09/2013 to 04/10/2013 – Nezhat Medical Center, Atlanta Center for Special Minimally Invasive Surgery & Reproductive Medicine, Georgia, Atlanta

Читать подробнее
Halit Kok
10 лет опыта
5.0
3 отзыва

Halit Kok

10 лет опыта
Turkey, Antalya
Hospitadent Dental Group - Antalya Clinic
Akif Saygin
15 лет опыта
5.0
1 отзыв
Turkey, Istanbul
VM Medical Park Pendik Hospital

Akif Saygin

15 лет опыта

Education and Expertise

2005 – Akdeniz University, Faculty of Medicine, Medical Education

2011 – Istanbul Göztepe Training and Research Hospital, Ophthalmology Specialization

Specialization Thesis: Our Grid Laser Results in the Treatment of Diabetic Macular Edema

Experience

Erzincan State Hospital

Mengücek Gazi Training and Research Hospital

Gebze Fatih State Hospital

Tuzla State Hospital

Courses and Certificates

56th TOD National Congress

ESCRS (The European Society of Cataract and Refractive Surgeons)

7th TOD Live Surgery Symposium

Cataract and Refractive Surgery Skills Transfer Course

Cataract and Refractive Surgery Live Applications

Professional Memberships

-Turkish Ophthalmology Association

-Turkish Medical Association, Istanbul Chamber

Читать подробнее

Education and Expertise

2005 – Akdeniz University, Faculty of Medicine, Medical Education

2011 – Istanbul Göztepe Training and Research Hospital, Ophthalmology Specialization

Specialization Thesis: Our Grid Laser Results in the Treatment of Diabetic Macular Edema

Experience

Erzincan State Hospital

Mengücek Gazi Training and Research Hospital

Gebze Fatih State Hospital

Tuzla State Hospital

Courses and Certificates

56th TOD National Congress

ESCRS (The European Society of Cataract and Refractive Surgeons)

7th TOD Live Surgery Symposium

Cataract and Refractive Surgery Skills Transfer Course

Cataract and Refractive Surgery Live Applications

Professional Memberships

-Turkish Ophthalmology Association

-Turkish Medical Association, Istanbul Chamber

Читать подробнее
Veysi Oner
18 лет опыта
5.0
2 отзыва

Veysi Oner

18 лет опыта
Turkey, Istanbul
Dunyagoz Eye Hospital Istanbul Altunizade
Hakan Alpay Karasu
35 лет опыта
Turkey, Ankara
Medipol University Ankara Dental Hospital

Hakan Alpay Karasu

35 лет опыта

 

Prof.Dr. Hakan Alpay Karasu, D.D.S. 

Department of Oral and Maxillofacial Surgery

Dean of the Faculty of Dentistry

Fields of Study and Interests

 

  • Orthognathic Surgery
  • Cleft Lip and Cleft Palate Surgery
  • Maxillofacial Cyst, Tumor Surgery
  • Advanced Surgical Bone Healing Techniques
  • Impacted Tooth Surgery
  • Dental Implants
  • TME surgery
  • Jaw-Face Traumas
  • Jaw joint disorders

 

Education

1998 - University of London, Department of Oral, Dental and Maxillofacial Surgery

  • 1991- Ankara University Faculty of Dentistry

Career

Ankara Medipol University Faculty of Dentistry

University of London, Faculty of Dentistry

  • Ankara University, Department of Oral, Dental and Maxillofacial Surgery
  • Gülhane Military Medicine Academy, Faculty of Dentistry

 

Publications and Congress Statements

1.Karasu HA., Okçu KM., Ortakoğlu K., Bayar GR., Aydıntuğ Y., "Treatment of Temporomandibular Joint Ankylosis with Temporalis Superficial Fascia Flap" Mil Med,2005;170(2):167
2. Özer L., Karasu HA., Aras K., Tokman B., Ersoy E., "Dentin Dysplasia Type 1: Report of Atypical Cases in The Permanent and Mixt Dentitions" Oral Surg Oral Med Oral Pathol Oral Radio/ Endod, 2004;98:85-90
3. Sayan NB., Üçok C., Karasu HA., Günhan Ö., "Peripheral Osteoma of The Oral and Maxillofacial Region: A Study of 35 New Cases" J Oral Maxillofac Surg, 2002;60:1299-1301
4. Doğan N., Üçok C., Korkmaz C., Üçok Ö., Karasu HA., "The Effects of Articaine Hydrochloride on Wound Healing: An Experimental Study" J Oral Maxillofac Surg, 2003;61:1467-1470
5. Karasu HA., Ortakoğlu K., Okçu M., Günhan Ö., "Osteochondroma of the Mandibular Condyle: Report of a Case and Review of the Literature" Mil Med, 2005;170(9):79

6. Altug Ataç AT., Karasu HA., Aytaç D., "Surgically Assisted Rapid Maxillary Expansion Compared with Orthopedic Rapid Maxillar Expansion" Angle Orthodontist, 2006;76(3):353-359
7. Sayan NB., Karasu HA., Uyanik LO., Aytaç D., "Two- stage Treatment of TMJ Ankylosis by Early Surgical Approach and Distraction Osteogenesis" J Craniofac Surg,2007;18(1):212-217
8. Üçok C., Karasu HA., Orhan K., Üçok Ö., Tuncer N., "Intravascular Papillary Endothelial Hyperplasia and Osteoma: A Case Report of an Individual with 2 Different Pathologies" Quintessence Int, 2007;38, (2):88-91
9. Kurt G. Altuğ-Atac AT., Ataç MS., Karasu HA., “Stability of SARME and OME after 3 years Follow-up.” The Angle Orthodontist. 2010;80(4):613-619
10. Kurt G., Altuğ-Atac AT., Ataç MS., Karasu HA., “Changes in Nasopharyngeal Airway Following Orthopedic and Surgically Assisted Rapid Maxillary Expansion” J Craniofac Surg 2010;21:312-317
11. Altuğ-Ataç AT., Ataç MS., Kurt G., Karasu HA., “Comparison of Surgically Assisted RME and Orthopedic RME: Changes in Nasal Structure” Int J Oral and Maxillofac Surg 2010;39:129-135.
12. Aydemir H, Memikoğlu U, Karasu H. Pharyngeal airway space, hyoid bone position and head posture after orthognathic surgery in Class III patients.” Angle Orthod. 2012 Nov;82(6):993-1000. doi: 10.2319/091911-597.1. Epub 2012 Apr 11. PMID:22500578
13. Efendiyeva R1, Aydemir H, Karasu H, Toygar-Memikoğlu U. “Pharyngeal airway space, hyoid bone position, and head posture after bimaxillary orthognathic surgery in Class III patients: Long-term evaluation.” Angle Orthod. 2014 Mar 7. [Epub ahead of print]
14. SUNAL AKTÜRK EZGİ, EREN HAKAN, GÖRÜRGÖZ CANSU, ORHAN KAAN, KARASU HAKAN ALPAY, AKAT BORA, TOYGAR MEMİKOĞLU TÜLİN UFUK (2020). Electromyographic, Ultrasonographic, and Ultrasound Elastographic Evaluation of the Masseter Muscle in Class III Patients Before and After Orthognathic Surgery. Journal of Craniofacial Surgery (Yayın No: 6276746)
15. Sahbaz Emir Bahman,CESUR EMRE,ALTUĞ DEMİRALP AYŞE TUBA,Ergül Kutay Can,KARASU HAKAN ALPAY,TOYGAR MEMİKOĞLU TÜLİN UFUK (2019). Is It Possible to Protract the Maxilla by Surgically Assisted Rapid Maxillary Expansion and Intermaxillary Class III Elastics? Turkish Journal of Orthodontics, 32(02), 96-104., Doi: 10.5152/Turkjorthod.2019.18060 (Yayın No: 5697928)
16. Aydemir H, Efendiyeva R, Karasu H, Toygar M, Tülin U (2015). Evaluation of Long-Term Soft Tissue Changes After Bimaxillary Orthognathic Surgery in Class III Patients. The Angle Orthodontist, 85(4), 631-637., Doi: 10.2319/062214-449.1

17. Karasu HA., Uyanık LO., Üçok C., Sayan NB., "The Use of Iliac Bone Greft on Maxillomandibular Defects" IntJ Oral Maxillofac Surg. 32(Supplement I) S39 (2003), 16 th International Conference on Oral and Maxillofacial Surgery, Athens, Greece.

18. Üçok C., Karasu HA., Akçam O., Uyanık LO., Üçok Ö., Sayan NB., "The Use Rapid External Distraction on Cleft Patient" IntJ Oral Maxillofac Surg. 32(Supplement I) S18 (2003), 16th International Conference on Oral and Maxillofacial Surgery, Athens, Greece.

19. Uyanık LO., Karasu HA., Aytaç D., "The use of Rigid External Distraction for Midface Hypoplasia" J Cranio-Maxillofac Surg. 34(Supplement 1) 155-156 (2006), Abstracts from the 18th Congress of The European Association for Cranio-Maxillofacial Surgery, Barcelona, Spain.

Читать подробнее

 

Prof.Dr. Hakan Alpay Karasu, D.D.S. 

Department of Oral and Maxillofacial Surgery

Dean of the Faculty of Dentistry

Fields of Study and Interests

 

  • Orthognathic Surgery
  • Cleft Lip and Cleft Palate Surgery
  • Maxillofacial Cyst, Tumor Surgery
  • Advanced Surgical Bone Healing Techniques
  • Impacted Tooth Surgery
  • Dental Implants
  • TME surgery
  • Jaw-Face Traumas
  • Jaw joint disorders

 

Education

1998 - University of London, Department of Oral, Dental and Maxillofacial Surgery

  • 1991- Ankara University Faculty of Dentistry

Career

Ankara Medipol University Faculty of Dentistry

University of London, Faculty of Dentistry

  • Ankara University, Department of Oral, Dental and Maxillofacial Surgery
  • Gülhane Military Medicine Academy, Faculty of Dentistry

 

Publications and Congress Statements

1.Karasu HA., Okçu KM., Ortakoğlu K., Bayar GR., Aydıntuğ Y., "Treatment of Temporomandibular Joint Ankylosis with Temporalis Superficial Fascia Flap" Mil Med,2005;170(2):167
2. Özer L., Karasu HA., Aras K., Tokman B., Ersoy E., "Dentin Dysplasia Type 1: Report of Atypical Cases in The Permanent and Mixt Dentitions" Oral Surg Oral Med Oral Pathol Oral Radio/ Endod, 2004;98:85-90
3. Sayan NB., Üçok C., Karasu HA., Günhan Ö., "Peripheral Osteoma of The Oral and Maxillofacial Region: A Study of 35 New Cases" J Oral Maxillofac Surg, 2002;60:1299-1301
4. Doğan N., Üçok C., Korkmaz C., Üçok Ö., Karasu HA., "The Effects of Articaine Hydrochloride on Wound Healing: An Experimental Study" J Oral Maxillofac Surg, 2003;61:1467-1470
5. Karasu HA., Ortakoğlu K., Okçu M., Günhan Ö., "Osteochondroma of the Mandibular Condyle: Report of a Case and Review of the Literature" Mil Med, 2005;170(9):79

6. Altug Ataç AT., Karasu HA., Aytaç D., "Surgically Assisted Rapid Maxillary Expansion Compared with Orthopedic Rapid Maxillar Expansion" Angle Orthodontist, 2006;76(3):353-359
7. Sayan NB., Karasu HA., Uyanik LO., Aytaç D., "Two- stage Treatment of TMJ Ankylosis by Early Surgical Approach and Distraction Osteogenesis" J Craniofac Surg,2007;18(1):212-217
8. Üçok C., Karasu HA., Orhan K., Üçok Ö., Tuncer N., "Intravascular Papillary Endothelial Hyperplasia and Osteoma: A Case Report of an Individual with 2 Different Pathologies" Quintessence Int, 2007;38, (2):88-91
9. Kurt G. Altuğ-Atac AT., Ataç MS., Karasu HA., “Stability of SARME and OME after 3 years Follow-up.” The Angle Orthodontist. 2010;80(4):613-619
10. Kurt G., Altuğ-Atac AT., Ataç MS., Karasu HA., “Changes in Nasopharyngeal Airway Following Orthopedic and Surgically Assisted Rapid Maxillary Expansion” J Craniofac Surg 2010;21:312-317
11. Altuğ-Ataç AT., Ataç MS., Kurt G., Karasu HA., “Comparison of Surgically Assisted RME and Orthopedic RME: Changes in Nasal Structure” Int J Oral and Maxillofac Surg 2010;39:129-135.
12. Aydemir H, Memikoğlu U, Karasu H. Pharyngeal airway space, hyoid bone position and head posture after orthognathic surgery in Class III patients.” Angle Orthod. 2012 Nov;82(6):993-1000. doi: 10.2319/091911-597.1. Epub 2012 Apr 11. PMID:22500578
13. Efendiyeva R1, Aydemir H, Karasu H, Toygar-Memikoğlu U. “Pharyngeal airway space, hyoid bone position, and head posture after bimaxillary orthognathic surgery in Class III patients: Long-term evaluation.” Angle Orthod. 2014 Mar 7. [Epub ahead of print]
14. SUNAL AKTÜRK EZGİ, EREN HAKAN, GÖRÜRGÖZ CANSU, ORHAN KAAN, KARASU HAKAN ALPAY, AKAT BORA, TOYGAR MEMİKOĞLU TÜLİN UFUK (2020). Electromyographic, Ultrasonographic, and Ultrasound Elastographic Evaluation of the Masseter Muscle in Class III Patients Before and After Orthognathic Surgery. Journal of Craniofacial Surgery (Yayın No: 6276746)
15. Sahbaz Emir Bahman,CESUR EMRE,ALTUĞ DEMİRALP AYŞE TUBA,Ergül Kutay Can,KARASU HAKAN ALPAY,TOYGAR MEMİKOĞLU TÜLİN UFUK (2019). Is It Possible to Protract the Maxilla by Surgically Assisted Rapid Maxillary Expansion and Intermaxillary Class III Elastics? Turkish Journal of Orthodontics, 32(02), 96-104., Doi: 10.5152/Turkjorthod.2019.18060 (Yayın No: 5697928)
16. Aydemir H, Efendiyeva R, Karasu H, Toygar M, Tülin U (2015). Evaluation of Long-Term Soft Tissue Changes After Bimaxillary Orthognathic Surgery in Class III Patients. The Angle Orthodontist, 85(4), 631-637., Doi: 10.2319/062214-449.1

17. Karasu HA., Uyanık LO., Üçok C., Sayan NB., "The Use of Iliac Bone Greft on Maxillomandibular Defects" IntJ Oral Maxillofac Surg. 32(Supplement I) S39 (2003), 16 th International Conference on Oral and Maxillofacial Surgery, Athens, Greece.

18. Üçok C., Karasu HA., Akçam O., Uyanık LO., Üçok Ö., Sayan NB., "The Use Rapid External Distraction on Cleft Patient" IntJ Oral Maxillofac Surg. 32(Supplement I) S18 (2003), 16th International Conference on Oral and Maxillofacial Surgery, Athens, Greece.

19. Uyanık LO., Karasu HA., Aytaç D., "The use of Rigid External Distraction for Midface Hypoplasia" J Cranio-Maxillofac Surg. 34(Supplement 1) 155-156 (2006), Abstracts from the 18th Congress of The European Association for Cranio-Maxillofacial Surgery, Barcelona, Spain.

Читать подробнее
Levent Akcay
26 лет опыта
5.0
2 отзыва
Turkey, Istanbul
Dunyagoz Eye Hospital Istanbul Altunizade

Levent Akcay

26 лет опыта

Curriculum Vitae

Place and Date of Birth

  • Manisa, 1965

Language Skills

  • English

Education and Experience

  • Uludağ University, School of Medicine
  • Dr. Lütfi Kırdar Kartal Training and Research Hospital (Specialization Training)

Number of scientific publications and articles

  • 201

Case Experience

  • Experience with more than 55,000 surgical cases during 32 years of active service as an ophthalmologist.

Memberships

  • American Academy of Ophthalmology
  • European Society of Ophthalmic Plastic and Reconstructive Surgery
  • Turkish Society of Ophthalmology
  • Turkish Republics Ophthalmology Society
  • Turkish Medical Association
  • Society of Fenerbahçe Fans
Читать подробнее

Curriculum Vitae

Place and Date of Birth

  • Manisa, 1965

Language Skills

  • English

Education and Experience

  • Uludağ University, School of Medicine
  • Dr. Lütfi Kırdar Kartal Training and Research Hospital (Specialization Training)

Number of scientific publications and articles

  • 201

Case Experience

  • Experience with more than 55,000 surgical cases during 32 years of active service as an ophthalmologist.

Memberships

  • American Academy of Ophthalmology
  • European Society of Ophthalmic Plastic and Reconstructive Surgery
  • Turkish Society of Ophthalmology
  • Turkish Republics Ophthalmology Society
  • Turkish Medical Association
  • Society of Fenerbahçe Fans
Читать подробнее
Фото до и после
Emrah Koksal
9 лет опыта
4.4
33 отзыва
Turkey, Istanbul
Medical Park Göztepe Hospital Complex

Emrah Koksal

9 лет опыта

Dr. Emrah Koksal is a plastic and reconstructive surgeon. He completed medical school at Trakya University (2011–2017). He trained in plastic and reconstructive surgery at Gülhane Military Medical Academy (2017–2023). He served at Gülhane Military Medical Academy (2018–2023) and at Hakkari Yüksekova State Hospital (2023–2025). He now practices at BAU MedicalPark Göztepe Hospital (2025–present).

He is a member of the International Society of Aesthetic Plastic Surgery (ISAPS) and the Turkish Plastic, Reconstructive and Aesthetic Surgery Association. He also belongs to the Aesthetic Plastic Surgery Association and the Reconstructive Microsurgery Association.

Читать подробнее

Dr. Emrah Koksal is a plastic and reconstructive surgeon. He completed medical school at Trakya University (2011–2017). He trained in plastic and reconstructive surgery at Gülhane Military Medical Academy (2017–2023). He served at Gülhane Military Medical Academy (2018–2023) and at Hakkari Yüksekova State Hospital (2023–2025). He now practices at BAU MedicalPark Göztepe Hospital (2025–present).

He is a member of the International Society of Aesthetic Plastic Surgery (ISAPS) and the Turkish Plastic, Reconstructive and Aesthetic Surgery Association. He also belongs to the Aesthetic Plastic Surgery Association and the Reconstructive Microsurgery Association.

Читать подробнее
Osman Ilhan
48 лет опыта
5.0
1 отзыв
Turkey, Ankara
Lokman Hekim Akay Hospital

Osman Ilhan

48 лет опыта

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

Читать подробнее

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

Читать подробнее
Deniz Konya
76 лет опыта
4.4
33 отзыва
Turkey, Istanbul
Medical Park Göztepe Hospital Complex

Deniz Konya

76 лет опыта

Spinal neurosurgeon

Читать подробнее

Spinal neurosurgeon

Hakan Terzi
26 лет опыта
На этой странице может быть представлена информация, касающаяся различных заболеваний, методов лечения и медицинских услуг, доступных в разных странах. Обратите внимание, что контент предоставляется исключительно в информационных целях и не должен рассматриваться как медицинский совет или руководство. Пожалуйста, проконсультируйтесь со своим врачом или квалифицированным медицинским работником, прежде чем начинать или менять лечение.